Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives

This publication has 112 references indexed in Scilit:

• Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged Bone
  Endocrinology, 2007
• Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial
  Diabetes, Obesity and Metabolism, 2007
• TCF7L2: the biggest story in diabetes genetics since HLA?
  Diabetologia, 2006
• Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
  The Journal of Clinical Endocrinology & Metabolism, 2006
• Assessment of diabetes screening by general practitioners in France: the EPIDIA Study
  Diabetic Medicine, 2006
• Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
  Nature Genetics, 2006
• The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
  Journal of Clinical Investigation, 1999
• Pas de Deux or More: the Sulfonylurea Receptor and K ⁺ Channels
  Science, 1995
• Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1989
• Impaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent Diabetes
  New England Journal of Medicine, 1988